Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Heather Woodcock-Bourne has worked on the following 26 EPO patent applications which have been published in the last five years:

EP12719083

GLYCOSIDE DERIVATIVES AND THEIR USES FOR THE TREATMENT OF DIABETES

IPC classification:
A61K 31/70, A61P 3/10, C07D 405/10
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP12719082

GLYCOSIDE DERIVATIVES AND USES THEREOF

IPC classification:
A61K 31/7034, A61P 3/00, C07D 407/10, C07D 413/10, C07D 417/10, C07H 13/04, C07H 15/04, C07H 15/12, C07H 15/14, C07H 15/203, C07H 19/044, C07H 19/24
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12727947

3-SPIROCYCLIC PIPERIDINE DERIVATIVES AS GHRELIN RECEPTOR AGONISTS

IPC classification:
A61K 31/438, A61P 1/00, C07D 471/10, C07D 487/10
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12742957

4 - PIPERIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

IPC classification:
A61K 31/4523, A61K 35/00, C07D 401/04, C07D 401/14, C07D 471/04, C07D 487/04, C07D 491/04, C07D 495/04, C07D 498/04, C07D 513/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12742995

4-OXO-3,5,7,8-TETRAHYDRO-4H-PYRANO {4,3-D} PYRMINIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

IPC classification:
A61K 31/519, A61P 35/00, C07D 491/052
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12742994

NOVEL 2-PIPERIDIN-1-YL-ACETAMIDE COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

IPC classification:
A61K 31/506, A61K 31/517, A61K 31/519, A61P 35/00, C07D 401/12, C07D 409/14, C07D 491/052
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12758894

PYRAZOLINE DERIVATIVES AND THEIR USE AS SELECTIVE ANDROGEN RECEPTOR MODULATORS

IPC classification:
A61K 31/416, A61P 5/26, C07D 487/04
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12770249

BENZOTHIAZOLONE COMPOUND

IPC classification:
A61K 31/428, A61P 21/00, C07D 277/68
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP13197275

Pyrrolopyrimidine compounds and their uses

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13710040

5-MEMBERED HETEROARYLCARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS

IPC classification:
A61P 27/00, C07D 231/14, C07D 401/06, C07D 401/14, C07D 403/10, C07D 403/12, C07D 403/14
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13709552

AMINOPYRIDINE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS

IPC classification:
A61K 31/4439, A61K 31/444, A61P 7/02, C07D 213/73, C07D 401/12, C07D 405/12, C07D 409/12, C07D 413/12, C07D 487/04, C07D 495/04
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13717320

SPIROHYDANTOIN COMPOUNDS AND THEIR USE AS SELECTIVE ANDROGEN RECEPTOR MODULATORS

IPC classification:
A61K 31/415, C07D 233/72, C07D 263/44, C07D 401/06, C07D 405/06, C07D 413/06
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13729090

L-MALATE SALT OF 2, 7 - DIAZA - SPIRO [4.5]DEC- 7 - YLE DERIVATIVES AND CRYSTALLINE FORMS THEREOF AS GHRELIN RECEPTOR AGONISTS

IPC classification:
A61K 31/438, A61P 1/00, C07D 471/10, C07D 487/10
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13192176

Salmonella conjugate vaccines

IPC classification:
A61K 47/48, A61P 31/04
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION REFUSED
EP13812075

SALTS OF BENZOTHIAZOLONE COMPOUND AS BETA-2-ADRENOCEPTOR AGONIST

IPC classification:
A61K 31/428, A61P 21/00, C07D 277/68
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP11779607

DIAZA-SPIRO[5.5]UNDECANES USEFUL AS OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/438, A61P 25/00, C07D 471/10, C07D 519/00
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13826612

PYRIMIDO [4,5-B]QUINOLINE-4,5 (3H,10H)-DIONES AS NONSENSE MUTATION SUPPRESSORS

IPC classification:
A61K 31/513, A61P 7/00, A61P 21/00, A61P 35/00, A61P 43/00, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14708700

FORMULATION COMPRISING BENZOTHIAZOLONE COMPOUND

IPC classification:
A61K 9/20, A61K 9/48, A61K 31/428
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP14806081

RING-FUSED BICYCLIC PYRIDYL DERIVATIVES AS FGFR4 INHIBITORS

IPC classification:
A61K 31/4353, A61K 31/437, A61K 31/4375, A61K 31/501, A61K 31/506, A61K 31/5377, A61K 31/5383, A61P 35/00, C07D 471/04, C07D 498/04, C07D 519/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP11745519

N-((6-AMINO-PYRIDIN-3-YL)METHYL)-HETEROARYL-CARBOXAMIDES AS INHIBITORS OF PLASMA KALLIKREIN

IPC classification:
A61K 31/4439, A61P 7/02, C07D 403/12, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/12, C07D 417/14
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15727117

COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS

IPC classification:
A61K 31/352, A61K 31/415, A61K 31/4245, A61K 31/44, A61K 31/506, A61P 19/02, C07D 491/18, C07D 493/08
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15774680

CARBOXAMIDE DERIVATIVES

IPC classification:
A61K 31/4192, A61P 9/12, A61P 19/02, A61P 19/04, A61P 19/08, C07D 403/12, C07D 487/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15725195

CARBOXAMIDE DERIVATIVES

IPC classification:
A61K 31/4155, A61K 31/422, A61P 9/12, A61P 11/00, A61P 19/02, A61P 19/08, C07D 413/12, C07D 413/14
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15731119

PYRIDOPYRIMIDINEDIONE DERIVATIVES

IPC classification:
A61K 31/38, A61K 31/505, C07D 471/04, C07D 495/14
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15731121

NAPHTHYRIDINEDIONE DERIVATIVES

IPC classification:
A61K 31/44, C07D 471/04, C07D 471/14, C07D 495/14
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15731120

PYRIMIDO[4,5-b]QUINOLINE-4,5(3H,10H)-DIONE DERIVATIVES

IPC classification:
A61K 31/519, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature